Proposal for Value-Based, Tiered Reimbursement for Tumor Biomarker Tests to Promote Innovation and Evidence Generation.
Dinan MA, Lyman GH, Schilsky RL, Hayes DF. Proposal for Value-Based, Tiered Reimbursement for Tumor Biomarker Tests to Promote Innovation and Evidence Generation. JCO Precision Oncology 2019, 3: 1-10. PMID: 35100733, DOI: 10.1200/po.19.00210.Peer-Reviewed Original ResearchTumor biomarker testsClinical utilityBiomarker testsFormal cost-effectiveness analysisHigh-level evidenceLow-level evidenceHealth care dollarsPrecision cancer careCost-effectiveness analysisCancer careEffective therapyCancer precision medicineTreatment decisionsTreatment selectionIneffective treatmentPoor reimbursement